Designing Microneedle Patch for Prophylaxis of Postoperative Atrial Fibrillation
ACS Nano · 2024
DOI: 10.1021/acsnano.4c00528 ↗At a glance
Journal article in ACS Nano, 2024. Written by Mingrui Cui and 11 co-authors. Institution: Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua U…. Major MEDLINE topics: Atrial Fibrillation, Needles. Cited 13 times so far (Crossref); 40 references. Funded by: Natural Science Foundation of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (original language)
Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery, which often occurs within 30 postoperative days, especially peaking at 2-3 days. Antiarrhythmic medications such as amiodarone are recommended in clinical practice for the prophylaxis and treatment of POAF. However, conventional oral administration is hindered due to delayed drug action and high risks of systemic toxicity, and emerging localized delivery strategies suffer from a limited release duration (less than 30 days). Herein, we develop a microneedle (MN) patch for localized delivery of amiodarone to the atria in a "First Rapid and Then Sustained" dual-release mode. Specifically, this patch is composed of a needle array integrated with an amiodarone-loaded reservoir for a sustained and steady release for over 30 days; and an amiodarone-containing coating film deposited on the needle surface via the Langmuir-Blodgett technique for a rapid release at the first day. Upon this design, only one MN patch enables a higher drug accumulation in the atrial tissue at the first day than oral administration and simultaneously remains therapeutical levels for over 30 days, despite at a significantly reduced drug dosage (5.08 mg in total versus ∼10 mg per day), thereby achieving ideal preventive effects and safety in a rat model. Our findings indicate that this MN device provides a robust and efficient delivery platform for long-term prophylaxis of POAF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
- Zhongshan Hospital Fudan University, Shanghai 200032, China.
- College of Chemistry and Chemical Engineering, Donghua University, Shanghai 201620, China.
- State Key Laboratory of Molecular Engineering of Polymers (Fudan University), Shanghai 200438, China.
ORCID profiles: Mingrui Cui, Xiaojun Zhou, Chuanglong He, Guang Yang
Funding
- Natural Science Foundation of Shanghai Municipality
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Cite
APA
Cui, M., Wang, W., Han, X., Lu, Z., Yang, X., Liu, L., Zhou, X., Chen, S., Wei, L., Chen, N., He, C., & Yang, G. (2024). Designing Microneedle Patch for Prophylaxis of Postoperative Atrial Fibrillation. ACS Nano. https://doi.org/10.1021/acsnano.4c00528
Vancouver
Cui M, Wang W, Han X, Lu Z, Yang X, Liu L, et al. Designing Microneedle Patch for Prophylaxis of Postoperative Atrial Fibrillation. ACS Nano. 2024. doi:10.1021/acsnano.4c00528
BibTeX
@article{Cui2024,
author = {Cui, Mingrui and Wang, Wenshuo and Han, Xiaoyue and Lu, Ziyi and Yang, Xuexia and Liu, Lingyan and Zhou, Xiaojun and Chen, Shuo and Wei, Lai and Chen, Nan and He, Chuanglong and Yang, Guang},
title = {Designing Microneedle Patch for Prophylaxis of Postoperative Atrial Fibrillation},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c00528}
}
EUVIMED